Stage IB Breast Cancer Suspended Phase 1 / 2 Trials for Copanlisib (DB12483)

IndicationStatusPhase
DBCOND0029218 (Stage IB Breast Cancer)Suspended1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03128619Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage I-IV Breast CancerTreatment